Share this
Rani Therapeutics – $73 Million IPO
Dynavax Technologies – $200 Million Convertible Notes Offering
TiVo and Xperi to Combine in $3 Billion All-Stock Merger
Sonim Technologies – $39 Million IPO
Rovi Receives Antitrust Clearance for TiVo Acquisition
Rovi Acquires TiVo for $1.1 Billion
Rovi Corporation Completes $345 Million Convertible Note Offering
Revance $110 Million Initial Public Offering
Depomed $240 Million Diabetes Drug Sale to PDL BioPharma
AcelRx Pharmaceuticals in Public Offering